Key result
Dimethylthiourea (DMTU) attenuated the impairment in afterload-adjusted maximum theoretical flow and normalized MEF-2, eHAND, and MHC isoform composition in chronic diabetic rats.
Why the study?
Does dimethylthiourea improve force-dependent and velocity-dependent indexes of cardiac contractility in streptozotocin-induced diabetic rats?
RCT
randomized
Does dimethylthiourea improve force-dependent and velocity-dependent indexes of cardiac contractility in streptozotocin-induced diabetic rats?
DMTU, a hydroxyl radical scavenger, improves velocity-dependent ventricular performance and reverses MHC isoform switch in chronic diabetic rats, suggesting a role for antioxidant therapy in diabetic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
DMTU improves contractility indexes in diabetic rat models; leaves open translation of antioxidant therapy to human diabetic cardiomyopathy.
Hydroxyl radicals and hydrogen peroxide are involved in the pathogenesis of systolic dysfunction in diabetic rats, but the precise mechanisms and the effect of antioxidant therapy in diabetic subjects have not been elucidated. We aimed to evaluate the effects of dimethylthiourea (DMTU), a potent hydroxyl radical scavenger, on both force-dependent and velocity-dependent indexes of cardiac contractility in streptozotocin (STZ)-induced early and chronic diabetic rats. Seventy-two hours and 8 wk after STZ (55 mg/kg) injection, diabetic rats were randomized to either DMTU (50 mg x kg(-1) x day(-1) ip) or vehicle treatment for 6 and 12 wk, respectively. All rats were then subjected to invasive hemodynamic studies. Maximal systolic elastance (E(max)) and maximum theoretical flow (Q(max)) were assessed by curve-fitting techniques in terms of the elastance-resistance model. Both normalized E(max) (E(maxn)) and afterload-adjusted Q(max) (Q(maxad)) were depressed in diabetic rats, concomitant with altered myosin heavy chain (MHC) isoform composition and its upstream regulators, such as myocyte enhancer factor-2 (MEF-2) and heart autonomic nervous system and neural crest derivatives (HAND). In chronic diabetic rats, DMTU markedly attenuated the impairment in Q(maxad) and normalized the expression of MEF-2 and eHAND and MHC isoform composition but exerted an insignificant benefit on E(maxn). Regarding preventive treatment, DMTU significantly ameliorated both E(maxn) and Q(maxad) in early diabetic rats. In conclusion, our study shows that DMTU has disparate effects on Q(maxad) and E(maxn) in chronic diabetic rats. The advantage of DMTU in chronic diabetic rats might involve normalization of MEF-2 and eHAND, as well as reversal of MHC isoform switch.
No takes yet. Share an insight, caveat, or question.
Yeih et al. (2009) conducted an RCT in streptozotocin (STZ)-induced early and chronic diabetic rats. dimethylthiourea (DMTU) vs. vehicle was evaluated on Maximal systolic elastance (E(max)) and maximum theoretical flow (Q(max)). Dimethylthiourea (DMTU) attenuated the impairment in afterload-adjusted maximum theoretical flow and normalized MEF-2, eHAND, and MHC isoform composition in chronic diabetic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: